We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.22%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$91.9B
AUM Growth
-$622M
Cap. Flow
-$6.3B
Cap. Flow %
-6.85%
Top 10 Hldgs %
34.23%
Holding
7,315
New
572
Increased
2,784
Reduced
3,105
Closed
393

Sector Composition

Rank Sector Weight
1 Technology 5.74%
2 Healthcare 5.25%
3 Financials 4.26%
4 Communication Services 3.9%
5 Consumer Discretionary 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATHX
5051
DELISTED
Athersys, Inc. Common Stock
ATHX
$70K ﹤0.01%
1,648
+1,591
+2,791% +$50.9K
CSFL
5052
DELISTED
CenterState Bank Corporation Common Stock
CSFL
$70K ﹤0.01%
2,709
-27,935
-91% -$701K
DEL
5053
DELISTED
Deltic Timber
DEL
$70K ﹤0.01%
892
+739
+483% +$56.7K
OKS
5054
CALL
DELISTED
Oneok Partners LP
OKS
$70K ﹤0.01%
1,300
-1,700
-57% -$84.9K
HW
5055
CALL
DELISTED
Headwaters Inc
HW
$70K ﹤0.01%
3,000
-200
-6% -$4.66K
BN icon
5056
CALL
Brookfield
BN
$104B
$69K ﹤0.01%
5,325
-1,962
-27% -$24.9K
EQNR icon
5057
PUT
Equinor
EQNR
$97.7B
$69K ﹤0.01%
4,000
+2,600
+186% +$46.7K
OXM icon
5058
CALL
Oxford Industries
OXM
$566M
$69K ﹤0.01%
1,200
+900
+300% +$49.8K
PRAA icon
5059
PRA Group
PRAA
$663M
$69K ﹤0.01%
2,061
+545
+36% +$20.5K
RMTI icon
5060
PUT
Rockwell Medical
RMTI
$28.4M
$69K ﹤0.01%
101
-148
-59% -$97.5K
ATCO
5061
PUT
DELISTED
Atlas Corp.
ATCO
$69K ﹤0.01%
9,900
+3,100
+46% +$25.6K
GLUU
5062
PUT
DELISTED
Glu Mobile Inc.
GLUU
$69K ﹤0.01%
30,500
+13,400
+78% +$28.9K
ENFC
5063
DELISTED
Entegra Financial Corp.
ENFC
$69K ﹤0.01%
+2,900
New +$65K
ARLZ
5064
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$69K ﹤0.01%
32,229
+29,976
+1,330% +$113K
CLDX icon
5065
Celldex Therapeutics
CLDX
$2.99B
$68K ﹤0.01%
1,243
+632
+103% +$32.9K
CMP icon
5066
CALL
Compass Minerals
CMP
$1.23B
$68K ﹤0.01%
1,000
+300
+43% +$22.9K
FBT icon
5067
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
$68K ﹤0.01%
645
IESC icon
5068
IES Holdings
IESC
$14.8B
$68K ﹤0.01%
3,760
-12,440
-77% -$240K
PODD icon
5069
Insulet
PODD
$11.5B
$68K ﹤0.01%
1,574
-2,438
-61% -$105K
FIG
5070
CALL
DELISTED
Fortress Investment Group Llc
FIG
$68K ﹤0.01%
8,500
-31,400
-79% -$212K
LJPC
5071
DELISTED
La Jolla Pharmaceutical Company
LJPC
$68K ﹤0.01%
2,270
+2,065
+1,007% +$52.7K
AES icon
5072
PUT
AES
AES
$10.5B
$67K ﹤0.01%
6,000
+2,400
+67% +$27.4K
AIR icon
5073
PUT
AAR Corp
AIR
$5.59B
$67K ﹤0.01%
2,000
CHRN
5074
ChronoScale Holdings
CHRN
$3.2B
$67K ﹤0.01%
+72
New +$61.4K
FBIN icon
5075
PUT
Fortune Brands Innovations
FBIN
$5.88B
$67K ﹤0.01%
1,287
+1,170
+1,000% +$57.4K

Similar funds

Barclays's Q1 2017 Portfolio in Review

As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.

By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.

  • Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
  • Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
  • Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
  • Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
  • Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
  • Barclays opened 572 new positions and closed 393 in Q1 2017.
  • Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.

Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.